Dhananjay B. Patankar
Vice President
ABLE
India
Biography
Dr. Dhananjay Patankar is Vice President – Biologics at Syngene International in Bangalore. Syngene is a leading contract service provider in India serving the pharma and biotech industry in drug discovery, development and manufacturing.Previously Dr. Patankar was involved in the biosimilar industry as Chief Operating Officer of Intas Biopharmaceuticals and as Sr Scientist at Wockhardt. In that tenure, he led the development and commercialization of several biosimilar products, and led the development of India’s first biosimilar product to receive marketing authorization in Europe (filgrastim, sold as Grastofil) as well as the world’s first Pegfilgrastim biosimilar.Dr. Patankar served as Chair of the USP Expert Committee for Medicines Compendium – Biologics (2010-15) and previously served on the Mashelkar Task Force for regulatory pathway for biosimilars in India (2004).Dr. Patankar is a Chemical Engineer and obtained his bachelors’ degree from the Indian Institute of Technology, Bombay and his Masters’ and PhD from the University of Utah (US) which was followed by a postdoctoral fellowship at Rutgers University (US).
Research Interest
Biopharmaceuticals
